Skip to content
buyWeak

Bvf Partners L P/il bought $2.8M of RPTX

owner at Repare Therapeutics Inc.. 783,709 shares at an average of $3.60, traded Nov 2, 2023, filed Nov 3, 2023.

Conviction score
35
Value
$2.8M
783,709 shares
Holdings after
485,083
+18% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    10% owner
    +12
  • Trade size
    $2.8M at market
    +25
  • Relative to holdings
    Holdings up 18%
    +3
  • Price context
    No price history yet
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (2 with prices)
    0
  • Outside holder
    A 10% owner who is not an officer or director
    -5

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0000921895-23-002458, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 2, 2023POpen-market purchase
Common Shares, no par value
+218,979$3.60$788k4,662,402Nov 3, 2023
Nov 2, 2023POpen-market purchase
Common Shares, no par value
+492,251$3.60$1.8M3,792,157Nov 3, 2023
Nov 2, 2023POpen-market purchase
Common Shares, no par value
+72,479$3.60$261k485,083Nov 3, 2023

Related signals

Other insiders at Repare Therapeutics Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
35Weak
RPTXsell 2
Repare Therapeutics Inc.
Steve Forte
EVP, CHIEF FINANCIAL OFFICER
$7,848
6,884 shares
-11%
23Weak
RPTXsell 2
Repare Therapeutics Inc.
Maria Koehler
EVP, CHIEF MEDICAL OFFICER
$4,099
3,596 shares
-2%
17Weak
RPTXsell 410b5-1
Repare Therapeutics Inc.
Steve Forte
EVP, CHIEF FINANCIAL OFFICER
$7,449
1,614 shares
-3%
10Weak
RPTXsell 410b5-1
Repare Therapeutics Inc.
Maria Koehler
EVP, CHIEF MEDICAL OFFICER
$3,718
800 shares
-0%
10Weak
RPTXsell 410b5-1
Repare Therapeutics Inc.
Michael Zinda
EVP, CHIEF SCIENTIFIC OFFICER
$3,999
860 shares
-1%
20Weak
RPTXsell 410b5-1
Repare Therapeutics Inc.
Lloyd Mitchell Segal
PRESIDENT AND CEO
$24k
5,141 shares
-5%
17Weak
RPTXsell 410b5-1
Repare Therapeutics Inc.
Steve Forte
EVP, CHIEF FINANCIAL OFFICER
$12k
2,475 shares
-6%
10Weak
RPTXsell 410b5-1
Repare Therapeutics Inc.
Maria Koehler
EVP, CHIEF MEDICAL OFFICER
$7,000
1,500 shares
-1%
26Weak
RPTXsell 410b5-1
Repare Therapeutics Inc.
Lloyd Mitchell Segal
PRESIDENT AND CEO
$37k
7,950 shares
-9%
10Weak
RPTXsell 410b5-1
Repare Therapeutics Inc.
Michael Zinda
EVP, CHIEF SCIENTIFIC OFFICER
$6,305
1,350 shares
-2%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Bvf Partners L P/il bought $2.8M of RPTX | InsiderTell